tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ONC Stock Latest News

BeOne Medicines price target raised to $394 from $385 at Barclays
The FlyBeOne Medicines price target raised to $394 from $385 at Barclays
19h ago
ONC
Zanubrutinib Update: What BeiGene’s BTK Intolerance Study Means for Oncology Investors
PremiumCompany Announcements
Zanubrutinib Update: What BeiGene’s BTK Intolerance Study Means for Oncology Investors
8d ago
ONC
Prelude Therapeutics’ PRT2527 Trial Completion: What Investors Should Watch in Hematologic Oncology
PremiumCompany Announcements
Prelude Therapeutics’ PRT2527 Trial Completion: What Investors Should Watch in Hematologic Oncology
10d ago
ONC
PRLD
BeiGene’s BGB-24714 Solid Tumor Trial Terminated: What It Means for Oncology Investors
PremiumCompany Announcements
BeiGene’s BGB-24714 Solid Tumor Trial Terminated: What It Means for Oncology Investors
10d ago
ONC
BeOne Medicines Targets CLL Leaders With New Phase 3 Head-to-Head Trial
PremiumCompany Announcements
BeOne Medicines Targets CLL Leaders With New Phase 3 Head-to-Head Trial
21d ago
ONC
BeOne Medicines upgraded to Outperform from Market Perform at Bernstein
PremiumThe FlyBeOne Medicines upgraded to Outperform from Market Perform at Bernstein
24d ago
ONC
BeOne Medicines price target raised to $405 from $390 at Morgan Stanley
Premium
The Fly
BeOne Medicines price target raised to $405 from $390 at Morgan Stanley
28d ago
ONC
BeOne Medicines’ Combo Cancer Trial Reaches Completion: What Investors Should Watch Next
Premium
Company Announcements
BeOne Medicines’ Combo Cancer Trial Reaches Completion: What Investors Should Watch Next
29d ago
ONC
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
PremiumThe Fly
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
29d ago
ONC
JAZZ
Zymeworks touts ‘unprecedented’ results from HERIZON-GEA-01 trial
PremiumThe Fly
Zymeworks touts ‘unprecedented’ results from HERIZON-GEA-01 trial
29d ago
ONC
JAZZ
Jazz reports efficacy, safety results from Phase 3 HERIZON-GEA-01 trial
PremiumThe Fly
Jazz reports efficacy, safety results from Phase 3 HERIZON-GEA-01 trial
29d ago
ONC
JAZZ
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint
PremiumThe Fly
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint
29d ago
ONC
BeOne Medicines Advances Early Cancer Trial for BG-75098, Signaling Steady Pipeline Progress
PremiumCompany AnnouncementsBeOne Medicines Advances Early Cancer Trial for BG-75098, Signaling Steady Pipeline Progress
1M ago
ONC
BeOne Medicines refinances debt, terminates prior credit facility
Premium
Company Announcements
BeOne Medicines refinances debt, terminates prior credit facility
2M ago
8K
ONC
BeOne Medicines Elevates Lai Wang to President, R&D Chief
Premium
Company Announcements
BeOne Medicines Elevates Lai Wang to President, R&D Chief
2M ago
8K
ONC
BeOne Medicines granted FDA Fast Track Designation for carcinoma candidate
PremiumThe Fly
BeOne Medicines granted FDA Fast Track Designation for carcinoma candidate
2M ago
ONC
Nurix Therapeutics price target raised to $30 from $24 at Mizuho
PremiumThe Fly
Nurix Therapeutics price target raised to $30 from $24 at Mizuho
2M ago
ONC
NRIX
BeOne Medicines announces new data on sonrotoclax
PremiumThe Fly
BeOne Medicines announces new data on sonrotoclax
2M ago
ONC
BeOne Medicines says FDA grants Priority Review to NDA for sonrotoclax
PremiumThe Fly
BeOne Medicines says FDA grants Priority Review to NDA for sonrotoclax
2M ago
ONC
BeOne Medicines initiated with a Buy at Truist
PremiumThe FlyBeOne Medicines initiated with a Buy at Truist
2M ago
ONC
BeOne Medicines Secures $1 Billion Financing Agreement
Premium
Company Announcements
BeOne Medicines Secures $1 Billion Financing Agreement
3M ago
8K
ONC
BeOne Medicines price target raised to $408 from $395 at RBC Capital
Premium
The Fly
BeOne Medicines price target raised to $408 from $395 at RBC Capital
3M ago
ONC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >